CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7
Phase 2 Completed
52 enrolled
Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer
Completed
360 enrolled
Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer
Phase 2 Completed
35 enrolled
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors
Phase NA Withdrawn
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
Terminated
114 enrolled 8 charts
Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496
Completed
175 enrolled
S9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313
Completed
2,100 enrolled
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma
Completed
397 enrolled
S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma
Completed
91 enrolled
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
Phase 1/2 Terminated
17 enrolled 7 charts
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
Unknown
1,200 enrolled
Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab
Completed
200 enrolled
Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel
Completed
180 enrolled
Biomarkers in Patients With Head and Neck Cancer
Completed
70 enrolled
Biomarkers in Tissue Samples From Patients With Hodgkin Lymphoma Enrolled on ECOG-2496 Clinical Trial
Completed
393 enrolled
HER-2 Mutations in Tumor Samples From Patients With Advanced Non-Small Cell Lung Cancer Treated on Clinical Trial ECOG-2598
Completed
44 enrolled
Study of Bone Marrow Samples From Patients With Acute Leukemia
Completed
40 enrolled
Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide
Completed
33 enrolled
Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690
Completed
307 enrolled
Biomarkers in Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab
Completed
200 enrolled
Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ
Completed
500 enrolled
Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based Therapy
Completed
225 enrolled
Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab
Completed
559 enrolled
Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab
Completed
363 enrolled
Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy
Completed
69 enrolled
Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate
Completed
80 enrolled
DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402
Completed
200 enrolled
Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia
Completed
257 enrolled
Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397
Completed
42 enrolled
Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301
Completed
155 enrolled
SURTIME
Phase 3 Unknown
99 enrolled
S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin
Completed
545 enrolled
Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
Completed
25 enrolled
Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors
Completed
50 enrolled
Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
Completed
31 enrolled
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma
Completed
5 enrolled
Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
Completed
20 enrolled
Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor
Completed
185 enrolled
Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia
Completed
32 enrolled
Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma
Completed
60 enrolled
Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531
Completed
1,000 enrolled
Studying Biomarkers in Samples From Patients With Rhabdomyosarcoma
Completed
40 enrolled
Biomarkers in Patients With Rhabdomyosarcoma
Completed
20 enrolled
Genetic Test in Detecting Minimal Residual Disease in Samples From Younger Patients Registered on the COG-AALL08B1 Trial
Completed
99 enrolled
Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421
Completed
90 enrolled
Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia
Completed
75 enrolled
Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia
Completed
149 enrolled
Biomarker Changes in Samples From Young Patients With Acute Myeloid Leukemia
Completed
15 enrolled
Obatoclax Mesylate in Samples From Young Patients With Acute Myeloid Leukemia
Completed
50 enrolled
Biomarkers in Tissue Samples From Young Patients With Liver Cancer
Completed
99 enrolled